ProMedix, Inc is a Medical Device Company Changing Sepsis Care

1. Improve Emergency/Critical Care of Sepsis Resuscitation and Identification

2. Improve Home Patient Monitoring

Promedix Headlines

Promedix launches ER based trial and has Manuscript Published

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix has launched a propsective observational study in the ER. Patients will have capillary refill measurements with our device in triage and during their resuscitation. The primary objective is to evaluate the ability of our device to improve early sepsis detection. A peer-reviewed manuscript has been published and attached below

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix had an abstract selected for presentation at the highly competitive/peer-reviewed American Heart Association Resuscitation Science Symposium: November 14-16,2020

https://professional.heart.org/en/meetings/resuscitation-science-symposium

2020 CTIP Innovation Grant Winner 08/2020

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

CTIP, Consortium for Technology and Innovation in Pediatrics, an FDA pediatric device consoritum received over 90 applications to their grant competition. Promedix was selected as a winner and it's ability to improve pediatric sepsis care

https://www.westcoastctip.org/cpi-grants

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix launched a clinical trial in the adult ICU and inpatient floors to validate their technology in sepsis resuscitation

Promedix Presents Results Nationally 05/2020

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Presents Results Nationally 05/2020

Promedix presented research findings at the highly competitive Pediatric Academic Society national meeting

Ideaship Invests in Promedix 11/2019

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Presents Results Nationally 05/2020

Promedix received an investment from Ideaship LLC to strategically develop their patent portfolio strategy. Ideaship serves as a trusted advisor as well.

https://www.gttgrp.com/promedix/

Business Oregon Innovation Grant Winner 06/2019

Promedix was an awardee of the highly competitive $100,000 Business Oregon Innovation Grant.

https://www.oregon4biz.com/About-Us/Investments-Report/Quarterly-Reports/Q4.php

ProMedix, Inc is a Medical Device Company Changing Sepsis Care

About Us

David Sheridan MD, MCR

David Sheridan MD, MCR

David Sheridan MD, MCR

Matthew Hansen MD, MCR

David Sheridan MD, MCR

David Sheridan MD, MCR

Andrew Kibler PhD

David Sheridan MD, MCR

Andrew Kibler PhD

Promedix Headlines

Promedix launches ER based trial and has Manuscript Published

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

2020 CTIP Innovation Grant Winner 08/2020

Promedix To Present at 2020 American Heart Association Resuscitation Science Symposium

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Presents Results Nationally 05/2020

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Presents Results Nationally 05/2020

Ideaship Invests in Promedix 11/2019

Promedix Launches Clinical Trial with 3rd Generation Device 08/2020

Promedix Presents Results Nationally 05/2020

Business Oregon Innovation Grant Winner 06/2019

Business Oregon Innovation Grant Winner 06/2019

Business Oregon Innovation Grant Winner 06/2019

Our Technology & Economic Modeling

Strong Evidence for Capillary Refill